Obese kidney transplant recipients have good outcomes.
Howard
R J
RJ
Department of Surgery, University of Florida College of Medicine, Gainesville, Florida 326100286, USA.
Thai
V B
VB
Patton
P R
PR
Hemming
A W
AW
Reed
A I
AI
Van der Werf
W J
WJ
Fujita
S
S
Karlix
J L
JL
Scornik
J C
JC
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D015992:Body Mass Index; D016572:Cyclosporine / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000453:epidemiology; D004359:Drug Therapy, Combination; D005190:Family; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000401:mortality / Q000502:physiology*; D019520:Living Donors; D009765:Obesity / Q000503:physiopathology*; D011183:Postoperative Complications / Q000453:epidemiology; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors; D014019:Tissue Donors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone